Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,313 warrant series at 1,052 companies. 775 in the money, 58 expiring in the next 30 days, 37 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A-2 Warrants (June 2026 private placement) | $0.3500 | $3.2M | 424B3, Jul 14, 2026Dilution tabAs of Oct 14, 2026 | ||||||||
| Commitment Fee Warrants (first installment, 2026 SEPA) | $1.80 | $3.2M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| December 2024 Warrants (2024 Warrants, registered direct offering) | $1.80 | $3.2M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Class C Warrants | $2.41 | $3.2M | F-3, Nov 6, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Class D Initial Warrants (October 2026 private placement) | $2.41 | $3.2M | F-3, Nov 6, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| February 2023 Warrants | $2.41 | $3.2M | F-3, Nov 6, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| October 2022 Warrants | $2.41 | $3.2M | F-3, Nov 6, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Executive Warrants (Ian Chan, Feb 7, 2025) | $0.5337 | $3.1M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 28, 2026 | ||||||||
| Private Placement Warrants (Sponsor) | $0.5337 | $3.1M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 28, 2026 | ||||||||
| Public Warrants (ACAB IPO, ABPWW) | $0.5337 | $3.1M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 28, 2026 | ||||||||
| Common Stock Warrants — remaining balance per warrant table at March 31, 2026 | $0.7263 | $3.1M | 10-Q, Oct 8, 2026Dilution tabAs of Oct 9, 2026 | ||||||||
| Pre-funded warrant issued to Crimson Swordblade Limited (Veloce acquisition) | $0.7263 | $3.1M | 10-Q, Oct 8, 2026Dilution tabAs of Oct 9, 2026 | ||||||||
| Public Warrants (LTRYW), including legacy AutoLotto warrants | $0.7263 | $3.1M | 10-Q, Oct 8, 2026Dilution tabAs of Oct 9, 2026 | ||||||||
| Arena First Closing Warrants (August 2024, $111.60) | $1.08 | $3.1M | 10-Q, Aug 13, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Arena Second Closing Warrants (October 2024, $69.52) | $1.08 | $3.1M | 10-Q, Aug 13, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Arena Third Closing Warrants (April 2025, $32.43) | $1.08 | $3.1M | 10-Q, Aug 13, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Arena waiver pre-funded warrant (July 2025) | $1.08 | $3.1M | 10-K, Apr 1, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Exchange Warrant – Index Equity US, LLC ($2.895) | $1.08 | $3.1M | 10-Q, Aug 13, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| First February 2026 Warrants ($3.1188) | $1.08 | $3.1M | 10-Q, Aug 13, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Initial April 2026 Warrants ($2.67) | $1.08 | $3.1M | 10-Q, Aug 13, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| July 2025 Pre-Funded Warrants | $1.08 | $3.1M | 10-K, Apr 1, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| July 2025 Warrants ($18.19) | $1.08 | $3.1M | 10-K, Apr 1, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| June 26, 2025 pre-funded waiver warrant | $1.08 | $3.1M | S-1/A, Sep 30, 2025Dilution tabAs of Nov 9, 2026 | ||||||||
| November 2026 Exchange Warrant – Alto Opportunity Master Fund ($2.67) | $1.08 | $3.1M | 8-K, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Peak One warrants – April 2024 tranche ($260.00) | $1.08 | $3.1M | 10-K, Apr 1, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Peak One warrants – February 15, 2024 tranche ($1,012.00) | $1.08 | $3.1M | 10-K, Apr 1, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Peak One warrants – March 21, 2024 tranche ($1,012.00) | $1.08 | $3.1M | 10-K, Apr 1, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Peak One warrants – May 2024 tranche ($304.00) | $1.08 | $3.1M | 10-K, Apr 1, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Second April 2026 Warrants ($2.67) | $1.08 | $3.1M | 8-K, Aug 28, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Second February 2026 Warrants ($3.1188) | $1.08 | $3.1M | 10-Q, Aug 13, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Series D Exchange Warrant – James D. Burnham ($2.895) | $1.08 | $3.1M | 8-K, Oct 5, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Underwriter's (Representative's) Warrants — The Benchmark Company, LLC (IPO, $5.00) | $0.2690 | $3.1M | 20-F, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| L1 Capital First Tranche Warrants (December 28, 2023, exercise price $51,496.39) | $3.38 | $3.1M | 10-K, Apr 15, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| October 2025 Inducement Advisor Warrants (WallachBeth designees, exercise price $180) | $3.38 | $3.1M | 424B5, Feb 27, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| October 2025 Inducement Warrants (exercise price $180, post 1-for-60) | $3.38 | $3.1M | 424B5, Feb 27, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Preferred Investment Options / Warrant (July 2022 private placement, exercise price $159,260.40) | $3.38 | $3.1M | 424B5, Feb 27, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series A Warrants (February 2025 PIPE, remaining, exercise price $1,255) | $3.38 | $3.1M | 424B5, Feb 27, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| April 2024 private placement common stock purchase warrants (Jiang Liu) | $2.07 | $3.1M | 10-K, Apr 15, 2026Dilution tabAs of Nov 3, 2026 | ||||||||
| May 2025 private placement common stock purchase warrants (1 Main Capital Partners) | $2.07 | $3.1M | DEFM14A, Dec 5, 2025Dilution tabAs of Nov 3, 2026 | ||||||||
| May 2025 private placement common stock purchase warrants (Lytton-Kambara Foundation) | $2.07 | $3.1M | SCHEDULE 13G/A, Aug 13, 2026Dilution tabAs of Nov 3, 2026 | ||||||||
| Roth placement agent warrants for July 2, 2025 registered public offering | $2.07 | $3.1M | 10-Q, Aug 19, 2026Dilution tabAs of Nov 3, 2026 | ||||||||
| Roth placement agent warrants for May 12, 2025 private placement (issued July 2, 2025) | $2.07 | $3.1M | S-1/A, Oct 9, 2025Dilution tabAs of Nov 3, 2026 | ||||||||
| Legacy warrants outstanding before FY2026 other than Series B (residual) | $5.42 | $3.1M | 10-K, Jul 29, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series B Warrants (May 2023 private placement) | $5.42 | $3.1M | 10-Q, Sep 14, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series C Investor Warrants (August 2025 private placement) | $5.42 | $3.1M | 10-Q, Sep 14, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series C Placement Agent Warrants (GP Nurmenkari designees) | $5.42 | $3.1M | 10-Q, Sep 14, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Settlement Warrants – Additional Warrants (H.C. Wainwright, July 29, 2025) | $5.42 | $3.1M | 10-Q, Sep 14, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Settlement Warrants – First Warrant Issuance (H.C. Wainwright, May 16, 2025) | $5.42 | $3.1M | 10-Q, Sep 14, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Stock warrants issued to SpringCard SAS | $0.3650 | $3.0M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Class A Common Share Purchase Warrants (January 2025 unit offering) - remaining | $0.8140 | $3.0M | 424B3, Mar 13, 2026Dilution tabAs of Oct 29, 2026 |
RDHLRedhill Biopharma Ltd.$0.3500Last price
Series A-2 Warrants (June 2026 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.2M
BCABBioAtla, Inc.$1.80Last price
Commitment Fee Warrants (first installment, 2026 SEPA)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.2M
BCABBioAtla, Inc.$1.80Last price
December 2024 Warrants (2024 Warrants, registered direct offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.2M
TOPSTOP Ships Inc.$2.41Last price
Class C Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.2M
TOPSTOP Ships Inc.$2.41Last price
Class D Initial Warrants (October 2026 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.2M
TOPSTOP Ships Inc.$2.41Last price
February 2023 Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.2M
TOPSTOP Ships Inc.$2.41Last price
October 2022 Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.2M
ABPOAbpro Holdings, Inc.$0.5337Last price
Executive Warrants (Ian Chan, Feb 7, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
ABPOAbpro Holdings, Inc.$0.5337Last price
Private Placement Warrants (Sponsor)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
ABPOAbpro Holdings, Inc.$0.5337Last price
Public Warrants (ACAB IPO, ABPWW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
SEGGSports Entertainment Gaming Global Corporation$0.7263Last price
Common Stock Warrants — remaining balance per warrant table at March 31, 2026
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
SEGGSports Entertainment Gaming Global Corporation$0.7263Last price
Pre-funded warrant issued to Crimson Swordblade Limited (Veloce acquisition)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
SEGGSports Entertainment Gaming Global Corporation$0.7263Last price
Public Warrants (LTRYW), including legacy AutoLotto warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
RENXRenX Enterprises Corp.$1.08Last price
Arena First Closing Warrants (August 2024, $111.60)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
RENXRenX Enterprises Corp.$1.08Last price
Arena Second Closing Warrants (October 2024, $69.52)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
RENXRenX Enterprises Corp.$1.08Last price
Arena Third Closing Warrants (April 2025, $32.43)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
RENXRenX Enterprises Corp.$1.08Last price
Arena waiver pre-funded warrant (July 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
RENXRenX Enterprises Corp.$1.08Last price
Exchange Warrant – Index Equity US, LLC ($2.895)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
RENXRenX Enterprises Corp.$1.08Last price
First February 2026 Warrants ($3.1188)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
RENXRenX Enterprises Corp.$1.08Last price
Initial April 2026 Warrants ($2.67)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
RENXRenX Enterprises Corp.$1.08Last price
July 2025 Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
RENXRenX Enterprises Corp.$1.08Last price
July 2025 Warrants ($18.19)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
RENXRenX Enterprises Corp.$1.08Last price
June 26, 2025 pre-funded waiver warrant
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
RENXRenX Enterprises Corp.$1.08Last price
November 2026 Exchange Warrant – Alto Opportunity Master Fund ($2.67)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
RENXRenX Enterprises Corp.$1.08Last price
Peak One warrants – April 2024 tranche ($260.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
RENXRenX Enterprises Corp.$1.08Last price
Peak One warrants – February 15, 2024 tranche ($1,012.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
RENXRenX Enterprises Corp.$1.08Last price
Peak One warrants – March 21, 2024 tranche ($1,012.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
RENXRenX Enterprises Corp.$1.08Last price
Peak One warrants – May 2024 tranche ($304.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
RENXRenX Enterprises Corp.$1.08Last price
Second April 2026 Warrants ($2.67)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
RENXRenX Enterprises Corp.$1.08Last price
Second February 2026 Warrants ($3.1188)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
RENXRenX Enterprises Corp.$1.08Last price
Series D Exchange Warrant – James D. Burnham ($2.895)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
GELSGelteq Limited Ordinary Shares$0.2690Last price
Underwriter's (Representative's) Warrants — The Benchmark Company, LLC (IPO, $5.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
HCTIHealthcare Triangle, Inc.$3.38Last price
L1 Capital First Tranche Warrants (December 28, 2023, exercise price $51,496.39)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
HCTIHealthcare Triangle, Inc.$3.38Last price
October 2025 Inducement Advisor Warrants (WallachBeth designees, exercise price $180)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
HCTIHealthcare Triangle, Inc.$3.38Last price
October 2025 Inducement Warrants (exercise price $180, post 1-for-60)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
HCTIHealthcare Triangle, Inc.$3.38Last price
Preferred Investment Options / Warrant (July 2022 private placement, exercise price $159,260.40)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
HCTIHealthcare Triangle, Inc.$3.38Last price
Series A Warrants (February 2025 PIPE, remaining, exercise price $1,255)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
SONMDNA X, Inc.$2.07Last price
April 2024 private placement common stock purchase warrants (Jiang Liu)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
SONMDNA X, Inc.$2.07Last price
May 2025 private placement common stock purchase warrants (1 Main Capital Partners)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
SONMDNA X, Inc.$2.07Last price
May 2025 private placement common stock purchase warrants (Lytton-Kambara Foundation)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
SONMDNA X, Inc.$2.07Last price
Roth placement agent warrants for July 2, 2025 registered public offering
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
SONMDNA X, Inc.$2.07Last price
Roth placement agent warrants for May 12, 2025 private placement (issued July 2, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
PMCBPharmaCyte Biotech, Inc.$5.42Last price
Legacy warrants outstanding before FY2026 other than Series B (residual)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
PMCBPharmaCyte Biotech, Inc.$5.42Last price
Series B Warrants (May 2023 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
PMCBPharmaCyte Biotech, Inc.$5.42Last price
Series C Investor Warrants (August 2025 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
PMCBPharmaCyte Biotech, Inc.$5.42Last price
Series C Placement Agent Warrants (GP Nurmenkari designees)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
PMCBPharmaCyte Biotech, Inc.$5.42Last price
Settlement Warrants – Additional Warrants (H.C. Wainwright, July 29, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
PMCBPharmaCyte Biotech, Inc.$5.42Last price
Settlement Warrants – First Warrant Issuance (H.C. Wainwright, May 16, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.1M
SCKTSocket Mobile, Inc.$0.3650Last price
Stock warrants issued to SpringCard SAS
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.0M
ICONIcon Energy Corp. Common stock$0.8140Last price
Class A Common Share Purchase Warrants (January 2025 unit offering) - remaining
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.0M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,062 dilution snapshots. 4,860 of 5,313 series state an exercise price and 3,370 an expiry date. 138 record when exercise begins; that count grows as companies are re-extracted. 623 series are left off because their figures could not be restated for a stock split. 19 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.